Medicare eliminates patient costs for colorectal cancer screening
S. 2949 — Colorectal Cancer Payment Fairness Act · Filed by Cory Booker (D-NJ) · 2 cosponsors · Introduced Sep 30, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill eliminates the coinsurance (patient cost-sharing) requirement for colorectal cancer screening tests covered by Medicare, making them fully covered at no out-of-pocket cost to beneficiaries. Currently, Medicare covers these screenings but requires patients to pay a percentage of the cost; this bill removes that requirement permanently starting in 2026.
Why we flagged it
The bill directly expands Medicare coverage by eliminating patient cost-sharing for a specific preventive health service, making it a straightforward public-health measure that reduces financial barriers to early cancer detection.
What the text implies
- Permanent elimination of coinsurance (striking the 2030 sunset) locks in full coverage indefinitely, increasing long-term Medicare spending on colorectal screening without a future review trigger.
- By removing cost-sharing, the bill may increase screening utilization rates among Medicare beneficiaries, potentially improving early cancer detection but also increasing volume-based costs to the program.
The full analysis lists 3 implications of this text.
Who stands to gain
Medicare beneficiaries (seniors and disabled individuals); Healthcare providers and facilities performing colorectal cancer screening